Effects of Probiotics on Serum Bilirubin Levels of newborns.

Effects of Lactobacillus Rhamnosus GG Supplementation in Reducing serum bilirubin in neonates after 35 weeks of gestation as compared to only breast milk. A tertiary care center based one year study- a randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066726

Enrollment

140

Registered

2024-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Probiotic administered to neonates for 5 days: probiotics will be adimnistered to new borns for a period of 5 days Control Intervention1: Control only breastmilk given to neonates: only

Eligibility

Inclusion criteria

Inclusion criteria: Newborns born after 35 weeks of gestation from day 3 of life to day 6 of life

Exclusion criteria

Exclusion criteria: Neonate of a gestational diabetic mother. Familial hematological disorder with signs of hemolysis. Neonates requiring intensive care admission during first 3 days of life. Neonates with congenital anomalies/malformations.

Design outcomes

Primary

Measure	Time frame
To assess the role of lactobacillus rhamnosus gg in reducing serum bilirubin levels in neonates.Timepoint: To assess the role of lactobacillus rhamnosus gg in reducing serum bilirubin levels in neonates over a period of first 5 days of life.	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Pavitra Alva

JNMC Belagavi

tanmayametgud@rediffmail.com9845395294

Outcome results